Cellebrite DI (CLBT) Projected to Post Earnings on Wednesday

Cellebrite DI (NASDAQ:CLBT - Get Free Report) is expected to announce its Q1 2025 earnings results before the market opens on Wednesday, May 14th. Analysts expect Cellebrite DI to post earnings of $0.09 per share and revenue of $109.36 million for the quarter. Cellebrite DI has set its FY 2025 guidance at EPS and its Q1 2025 guidance at EPS.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 70.54% and a positive return on equity of 58.70%. On average, analysts expect Cellebrite DI to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cellebrite DI Stock Performance

Shares of CLBT opened at $19.47 on Wednesday. Cellebrite DI has a 52 week low of $10.25 and a 52 week high of $26.30. The stock has a 50 day moving average price of $18.86 and a two-hundred day moving average price of $20.21. The firm has a market capitalization of $4.66 billion, a P/E ratio of -14.01, a P/E/G ratio of 4.27 and a beta of 1.44.

Analyst Upgrades and Downgrades

CLBT has been the subject of a number of analyst reports. Lake Street Capital increased their price target on Cellebrite DI from $17.00 to $26.00 and gave the company a "buy" rating in a research report on Friday, February 14th. Needham & Company LLC reiterated a "buy" rating and issued a $28.00 target price on shares of Cellebrite DI in a report on Wednesday, April 2nd. Finally, JPMorgan Chase & Co. raised their price target on shares of Cellebrite DI from $24.00 to $28.00 and gave the company an "overweight" rating in a research report on Tuesday, February 11th. Seven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $23.43.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.